Trial intelligence / Profile preview

Econazole Nitrate Foam vs Cream in Pediatric Interdigital Tinea Pedis

NCT01696799Phase 2Completed

Sponsor
AmDerma Pharmaceuticals
Start
Sep 2011
Primary completion
Apr 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, single-blind trial of econazole in interdigital tinea pedis (TP) (3 arms), sponsored by AmDerma Pharmaceuticals. Primary endpoints: Plasma Levels of Econazole Nitrate at 28 days and Investigator Assessment of Response to Treatment at 28 days. Started Sep 2011; status: completed.

02

Drugs

econazole
03

Conditions

interdigital tinea pedis (TP)

Beyond the preview

Go deeper on NCT01696799.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01696799.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call